Abstract: The disclosure discloses a touch display panel, a method for driving the same, and a display device. The touch display panel includes data lines, a source drive circuit, a first signal line, a second signal line, a synchronous signal line, a plurality of first switches, and a plurality of second switches, in a touch stage, the first switches are turned on under the control of a signal output from the first signal line, a signal synchronous with a touch signal is input to the data lines by the synchronous signal line, and the second switches are turned off under the control of a signal output from the second signal line; and in a display stage, the first switches are turned off under the control of a signal output from the first signal line, and the second switches are turned on under the control of a signal output from the second signal line.

Abstract: The present disclosure relates to the field of display technologies, and especially discloses a backlight device and a method for manufacturing the same. The backlight device includes a backlight source, a light guide plate, a reflective layer, an optical adhesive layer and an outcoupling structure. Specifically, in the backlight device, the reflective layer and the light guide plate are located on opposite sides of the backlight source respectively.

Abstract: The present disclosure provides a lighting device and method. The device includes a lighting module configured to generate light required for illumination; a processing module configured to determine a target illumination area based on one or more environmental factors around the lighting device; and a lighting control module configured to project light emitted from the lighting module to the target illumination area. The method includes determining a target illumination area based on one or more environmental factors; and controlling, by a lighting control module, a lighting module to generate and project light to the target illumination area.

Abstract: The present disclosure relates to a manufacturing method for a light adjusting structure, a light adjusting structure, a backlight module and a display device. The manufacturing method includes: providing a light guide plate; forming a substrate having a plurality of micro structures; and placing the micro structures upside down on a light exit surface of the light guide plate; heating the light guide plate; adhering the tips of the micro structures to the light guide plate; cooling the light guide plate; and forming a first reflective layer on the side surface of each micro structure.

Abstract: The present disclosure discloses a backlight and a manufacturing method thereof, a light guide plate and a manufacturing method thereof and a display device. The backlight is a direct type backlight, and the backlight includes: a light guide plate having a main body of a plate shape, a plurality of light emitting units that are placed toward to a plane side of the light guide plate; where the light guide plate comprises a Quantum Dot (QD) layer on a first surface of the main body wherein the first surface is substantially flat.

Abstract: The present disclosure provides a light guide plate, a manufacturing method thereof, a backlight source and a display device. The light guide plate includes: a first surface, a second surface, and at least one blazed gating structure that is on the second surface of the light guide plate, wherein light incident from the first surface of the light guide plate forms a total reflection in the light guide plate after the light irradiates the at least one blazed gating structure and is diffracted by the at least one blazed grating structure.

Abstract: The present disclosure provides a new cytidine derivative having the general formula (I), and applications thereof: As demonstrated by experiments on the growth inhibition effect of the new cytidine derivative of the present invention on HCT-116 colon cancer xenografts in tumor-bearing nude mice, the compound of the present invention has high anti-tumor activity, data of impacts on weight of nude mice bearing human colon cancer HCT-116 and data of mortality rate showed that the toxicity of the compound is comparatively low.

Abstract: This disclosure relates to a camera device and a method for capturing images by using the same. The camera device includes a liquid crystal lens array composed of a plurality of liquid crystal sub-lenses, an image sensor and a drive module. A preset distance is provided between the liquid crystal lens array and the image sensor, and the drive module is electrically connected with the liquid crystal lens array. The drive module is configured to adjust a focus of each liquid crystal sub-lens during capturing based on a distance between an object to be captured and a corresponding liquid crystal sub-lens, such that light rays from each object are focused respectively in a plane where the image sensor is located after passing through the corresponding liquid crystal sub-lens.

Abstract: The present disclosure provides a new cytidine derivative having the general formula (I), and applications thereof: As demonstrated by experiments on the growth inhibition effect of the new cytidine derivative of the present invention on HCT-116 colon cancer xenografts in tumor-bearing nude mice, the compound of the present invention has high anti-tumor activity, data of impacts on weight of nude mice bearing human colon cancer HCT-116 and data of mortality rate showed that the toxicity of the compound is comparatively low.

Abstract: (20S) esters of camptothecin analogs are provided. The compounds are (20S) esters of an aminoalkanoic acid or an imidoalkanoic acid and camptothecin, which is optionally substituted at the 7, 9, 10, 11, and 12 positions of the camptothecin ring. The compounds are useful for treating cancer.

Abstract: (20S) esters of camptothecin analogs are provided. The compounds are (20S) esters of an aminoalkanoic acid or an imidoalkanoic acid and camptothecin, which is optionally substituted at the 7, 9, 10, 11, and 12 positions of the camptothecin ring. The compounds are useful for treating cancer.

Abstract: (20S) esters of camptothecin analogs are provided. The compounds are (20S) esters of an aminoalkanoic acid or an imidoalkanoic acid and camptothecin, which is optionally substituted at the 7, 9, 10, 11, and 12 positions of the camptothecin ring. The compounds are useful for treating cancer.

Abstract: (20S) esters of camptothecin analogs are provided. The compounds are (20S) esters of an oxyalkanoic acid and camptothecin, which is optionally substituted at the 7, 9, 10, 11, and 12 positions of the camptothecin ring. The compounds are useful for treating cancer.